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Abstract
Highly pathogenic avian influenza H5N1 viruses have devastated the poultry industry in many countries of the eastern
hemisphere. Occasionally H5N1 viruses cross the species barrier and infect humans, sometimes with a severe clinical
outcome. When this happens, there is a chance of reassortment between H5N1 and human influenza viruses. To assess the
potential of H5N1 viruses to reassort with contemporary human influenza viruses (H1N1, H3N2 and pandemic H1N1), we
used an in vitro selection method to generate reassortant viruses, that contained the H5 hemagglutinin gene, and that have
a replication advantage in vitro. We found that the neuraminidase and matrix gene segments of human influenza viruses
were preferentially selected by H5 viruses. However, these H5 reassortant viruses did not show a marked increase in
replication in MDCK cells and human bronchial epithelial cells. In ferrets, inoculation with a mixture of H5N1-pandemic
H1N1 reassortant viruses resulted in outgrowth of reassortant H5 viruses that had incorporated the neuraminidase and
matrix gene segment of pandemic 2009 H1N1. This virus was not transmitted via aerosols or respiratory droplets to naı¨ve
recipient ferrets. Altogether, these data emphasize the potential of avian H5N1 viruses to reassort with contemporary
human influenza viruses. The neuraminidase and matrix gene segments of human influenza viruses showed the highest
genetic compatibility with HPAI H5N1 virus.
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Introduction
Since the late 1990s, highly pathogenic avian influenza (HPAI)
viruses of the H5N1 subtype have devastated the poultry industry
of numerous countries of the eastern hemisphere. After 2004,
H5N1 has spread from Asia to Europe, Africa, and the Middle
East, resulting in the killing or culling of hundreds of millions of
domestic birds. Occasionally, HPAI H5N1 viruses cross the
species barrier and infect humans, sometimes with a severe clinical
outcome. This direct transmission of HPAI H5N1 virus to humans
was first detected in 1997 [1] and has continued to be reported
ever since [2]. Luckily, these viruses do not transmit efficiently
between humans. However, they may gain the ability to spread
efficiently among humans through either virus adaptation to the
new host, genetic reassortment (ie genetic mixing of viruses) with
contemporary human influenza viruses, or both [3–6]. Reassort-
ment has proven to be an important mechanism for influenza
viruses to evolve. The influenza pandemics of 1957, 1968 and
2009 were the result of reassortment events [7–9].
To date, reassortment of H5N1 viruses with human influenza
viruses has not been detected in nature. However, co-infection of
H5N1 and human viruses in humans or pigs may provide a new
opportunity for reassortment and the subsequent emergence of
viruses with pandemic potential. Therefore, it is important to
investigate the genetic compatibility of the genes of potential
parental strains.
In previous studies, reassortment of avian H5N1 and human
H3N2 has been investigated extensively in vivo [10–12]. It was
found that H5N1-H3N2 reassortment resulted in a more
pathogenic H5 virus in mice [10,12]. Furthermore, reassortment
was found to occur readily in vivo, with a high probability in the
ferret upper respiratory tract [11]. However, none of the tested
H3N2-H5N1 reassortant viruses had gained the ability to be
transmitted between ferrets.
Recent studies have also investigated the replication kinetics of
many reassortant viruses between the 2009 pandemic H1N1
(pH1N1) and H5N1 influenza virus in vitro and in vivo [13–15]. Co-
infection of cultured cells with pH1N1 and H5N1 showed that
these two viruses have high genetic compatibility and that some of
these viruses displayed better replication kinetics in vitro [13]. In
addition, increased pathogenicity was observed for a reassortant
pH1N1 containing an H5N1 HA in mice [15].
Avian H5N1 and human influenza viruses display different
replication characteristics in primary cell cultures. Avian influenza
PLOS ONE | www.plosone.org 1 March 2013 | Volume 8 | Issue 3 | e59889
viruses can infect human airway epithelium cells, although
replication may be limited compared to human influenza viruses
because of a nonoptimal cellular tropism [16]. This system offers
an alternative to study virus and/or host properties required for
adaptation or reassortment of influenza viruses. It was studied that
co-infection of cells with viruses carrying HA of avian and human
influenza viruses take place when the cells provide both receptors
[17].
Here, we investigated the ability of HPAI H5N1 and
contemporary human H3N2, H1N1 and pH1N1 influenza
viruses to reassort, by means of an in vitro selection method
using reverse genetics and serial passaging under limited dilution
conditions as described before [18]. In contrast to double
infection with 2 viruses, this method allows the production of
gene segments at approximately similar copy numbers upon
transfection, after which in vitro or in ovo viruses may differ in
replication capacity. In addition, avian H5N1 outcompetes
human influenza viruses in co-infection experiments [13]. In this
way, a bias towards reassortants produced is thus prevented.
The reassortants that were selected during this in vitro selection
experiment were subsequently evaluated for replication kinetics
in MDCK cells and normal human bronchial epithelial (NHBE)
cultures. In addition, to study wether reassortants were
produced with a replication advantage over the parental viruses
in vivo, ferrets were inoculated with a mixture of reassortant
viruses between pH1N1 and H5N1. The genetic composition of
these reassortant mixtures were followed over time. Simulta-
neously, the transmissibility of these viruses was evaluated in a
ferret model via aerosols or respiratory droplets.
Materials and Methods
Ethics Statement
Animals were housed and experiments were conducted in
strict compliance with European guidelines (EU directive on
animal testing 86/609/EEC) and Dutch legislation (Experiments
on Animal Act, 1997). All animal experiments were approved
by the independent animal experimentation ethical review
committee ‘stichting DEC consult’ (Erasmus MC permit
number EUR 1621) and were performed under animal biosafety
level 3+ conditions as described elsewhere [6]. Animal welfare
was observed on a daily basis, and all animal handling was
performed under light anesthesia using ketamine to minimize
animal suffering. Influenza virus sero-negative 6 month old
female ferrets (Mustella putorius furo), weighing 800–1000 g., were
obtained from a commercial breeder. All experiments involving
H5N1 transmission were conducted prior to the institution of
the current moratorium.
Cells and Viruses
Madin-Darby Canine kidney (MDCK) cells were cultured in
EMEM (Cambrex, Heerhugowaard, the Netherlands) supple-
mented with 10% FCS, 100 IU/ml penicillin, 100 mg/ml
streptomycin, 2 mM glutamine, 1.5 mg/ml sodiumbicarbonate
(Cambrex), 20 mM Hepes (Cambrex), and 0.1 mM non-essential
amino acids (MP Biomedicals Europe, Illkirch, France). 293T cells
were cultured in DMEM (Cambrex) supplemented with 10%
FCS, 100 IU/ml penicillin, 100 mg/ml streptomycin, 2 mM
glutamine, 1 mM sodium pyruvate, and non-essential amino
acids.
All eight gene segments of influenza virus isolates A/Nether-
lands/602/2009 (pH1N1), A/Netherlands/213/2003 (H3N2), A/
Netherlands/26/2007 (sH1N1) and A/Indonesia/5/2005 (H5N1)
were amplified by reverse transcription polymerase chain reaction,
cloned in a modified version of the bidirectional reverse genetics
plasmid pHW2000 [19,20], and subsequently used to generate
recombinant virus by reverse genetics as described elsewhere [19].
All in vitro selection experiments, growth curves and virus titrations
were performed under ABSL3+ conditions.
Generation of the Reassortant Viruses
Reverse genetics was used to generate mixtures of reassortant
viruses in 293T cells by co-transfecting eight plasmids that encode
the H5N1 virus genome together with seven plasmids encoding
the pH1N1, H3N2 or sH1N1 virus genome. The HA gene of these
human viruses was omitted to make sure that only viruses with the
HA of H5N1 virus were generated, as described previously [18].
The 293T cell supernatants were subsequently passaged in
quadruplicate under limiting dilution conditions by using ten-fold
serial dilutions in MDCK cells three times to enable selective
outgrowth of viruses with high in vitro replication rates. Next, the
genome composition of these viruses was determined by Sanger
sequencing using conserved primers targeting the noncoding
regions of each gene segment. Reverse genetics was subsequently
used to produce reassortant viruses with the different gene
compositions as identified by sequencing.
Virus Titrations on MDCK Cells
Virus titers in ferret nasal and throat swabs, or samples from
replication curves were determined by end-point titration in
MDCK cells. MDCK cells were inoculated with tenfold serial
dilutions of each sample, washed one hour after inoculation with
phosphate-buffered saline (PBS), and cultured in 200 ml of
infection medium, consisting of EMEM supplemented with
100 U/ml penicillin, 100 mg/ml streptomycin, 2 mM glutamine,
1.5 mg/ml sodiumbicarbonate, 20 mM Hepes, non-essential
amino acids, and 20 mg/ml trypsin (Cambrex). Three days after
inoculation, the supernatants of inoculated cell cultures were tested
for agglutinating activity using turkey erythrocytes as an indicator
of virus replication in the cells. Infectious virus titers were
calculated from 4 replicates by the method of Spearman-Karber
[21].
Replication Kinetics in MDCK Cells
Multicycle replication curves were generated by inoculating
MDCK cells at a multiplicity of infection (MOI) of 0.01 50 percent
tissue culture infectious doses (TCID50) per cell in duplicate.
Supernatants were sampled at 6, 12, 24, and 48 hours after
inoculation, and virus titers in these supernatants were determined
by means of end-point titration in MDCK cells as described
above.
Culture of NHBE Cells
Normal human bronchial epithelial (NHBE) cells were
obtained from Clonetics (Basel, Switzerland) and used at
passage 3–4. Undifferentiated NHBE cells were grown on
30 mg/ml type I collagen-coated 75 cm2 flasks in serum-free
bronchial epithelial cell basal medium (BEBM) supplemented
with BEBM SingleQuots (Clonetics). At 60–80% confluency,
cells were trypsinized and seeded at a cell density of 16104
viable cells onto type I collagen-coated 6.5 mm transwell inserts
with 0.4 mm pore size (Corning, Amsterdam, The Netherlands).
The growth medium consisted of a 1:1 mixture of complete
BEBM and DMEM, supplemented with 15 ng/ml retinoic acid
(Sigma-Aldrich). The medium was replaced with fresh medium
every other day until cells reached confluency. Subsequently, an
air-liquid interface (ALI) was created by removing medium from
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the apical side to promote mucocilliary differentiation. The
medium was refreshed basolaterally and the apical side was
washed with Dulbecco’s PBS (DPBS, Lonza) at 37uC every
other day. Well-differentiated (wd-) NHBE cells were inoculated
with influenza virus, 21 days after ALI, at which stage beating
cilia and mucus production were clearly detectable.
wdNHBE Cell Characterization
wdNHBE cells on transwell filters were washed with PBS,
fixed with 4% paraformaldehyde for 20 min at room temper-
ature (RT) and subsequently washed with PBS 0.1% Tween and
permeabilized with 1% Triton X-100 in PBS. After washing
with PBS and blocking with PBS 5% BSA-0.1% Tween, ciliated
cells were identified by staining with mouse monoclonal b-
Tubulin antibody (KLINIPATH, Duiven, The Netherlands).
Goblet cells were identified by mouse Mucin 5AC antibody
(MUC5AC, ITK DIAGNOSTIC BV, Uithoorn, The Nether-
lands). The cultures were subsequently incubated with a
secondary goat anti-mouse IgG (H+L) texas red labelled
antibody (Alexa Fluor H 594, Invitrogen) to visualize ciliated
cells or goblet cells. In addition, cell cultures stained for the
presence of ciliated cells were double stained to also visualize
the tight junctions: cells were incubated with a ZO-1 N-Term
antibody (Invitrogen), followed by incubation with a secondary
swine anti-rabbit FITC labelled antibody (DAKO, Enschede,
Netherlands). The transwell filters were cut off after staining,
mounted on slides with Prolong Gold Mount (Vectashield,
Peterborough, UK) and analysed using a fluorescence imaging
microscope (Leica Microsystems).
Lectin Staining of Differentiated NHBE Cells
The wdNHBE cultures were washed with DPBS to remove
overlaying mucus and incubated for 1 hour at 4uC with biotin-
labeled lectines sambucus nigra agglutinin (SNA; specific for sialic
acid a2.6 Gal; 4 mg/ml; SANBIO BV, Uden, Netherlands) or
Maackia amurensis agglutinin II (MAAII; specific for sialic acid
a2.3 Gal; 20 mg/ml; BIO-CONNECT, Huissen, Netherlands) in
Tris-buffered saline (TBS; pH 7.2) containing 1% BSA and 1 mM
Mg2+, Ca2+, and Mn2+. Next, the cells were washed with TBS and
fixed with 4% paraformaldehyde. After washing, the cultures were
incubated for 1 hour at RT with streptavidin-horseradish perox-
idise FITC-labeled conjugate (DAKO) in 1% BSA-TBS. Cultures
were washed, permeabilized and stained for cilia as described
above and analysed by confocal laser scanning microscopy using a
LSM700 system fitted on an Axio Observer Z1 inverted
microscope (Zeiss). Images were generated using Zen software.
Replication Kinetics in Differentiated NHBE Cells
The wdNHBE cells were washed with DPBS to remove
overlaying mucus and duplicates were inoculated via the apical
side, with virus of interest at a MOI of 0.02 in 100 ml. After one
hour of incubation at 37uC the inoculum was removed, cells were
washed three times with DPBS and once with growth medium.
The last wash step with growth medium was collected for virus
titration as time point t = 0. At 6, 12, 24, and 48 hours after
inoculation, 100 ml of growth medium was added to the apical side
of the trans well of each culture to collect virus samples. After
10 min of incubation at 37uC, the medium was collected and
stored at 280uC for virus titration in MDCK cells.
Ferret Transmission Experiment
The ferret model to test for aerosol or respiratory droplet
transmission was described previously [22]. In the transmission
experiment, two influenza virus sero-negative female ferrets were
individually housed in transmission cages and inoculated intrana-
sally, divided over both nostrils (26250 ml), with 107.3 TCID50 of
MDCK passage 1 (MDCKP1) of the H5N1-pH1N1 reassortant
virus mixture (eight H5N1 and seven pH1N1 plasmids, without
the pH1N1 HA, were transfected in 293T cells and supernatant
was subsequently passaged on MDCK cells). At 1 day post
inoculation (dpi), naı¨ve recipient ferrets were individually placed in
a transmission cage adjacent to a donor ferret. The animals were
separated by two stainless steel grids to allow airflow from the
donor to the recipient ferret but to prevent direct contact- and
fomite transmission. Nasal and throat swabs were collected at 1, 3,
5 and 7 dpi from donor ferrets and at 1, 3, 5 and 7 days post
exposure (dpe) from the recipient animals. Donor ferrets were
euthanized at 7 dpi and recipient ferrets at 7 dpe. Virus titers were
determined in collected swabs by means of end-point titration in
MDCK cells.
Analysis of Viral Genome Composition in Ferrets by
Pyrosequencing
Pyrosequencing, a method to detect single nucleotide polymor-
phisms (SNP) [23], was used to determine the exact proportion of
H5N1 and pH1N1 gene segments in the donor ferrets inoculated
with the MDCK P1 H5N1-pH1N1 reassortant mixture. RNA was
isolated from the throat swabs collected at 1, 3, 5 and 7 days dpi.
After cDNA synthesis, conserved primers were used for each gene
segment to amplify a small PCR product of approximately 100 bp
(Table 1). These fragments were next sequenced using the
Pyromark Q24 pyrosequencing platform (Qiagen, Venlo, The
Netherlands) with a specific sequence primer (Table 1).
Table 1. Primers used for pyrosequencing.
Primers Sequence (59-39)
Forward PB2 H5N1/H1N1 GCAGGTCAAATATATTCAATATGG
Reverse PB2 H5N1/H1N1 GATTATGGCCATATGGTCCAC * biotin
Sequence primer TCAATATGGAGAGAATAAAA
Forward PB1 H5N1/H1N1 CAGGATACACCATGGACACAGT
Reverse PB1 H5N1/H1N1 CCTCAGGTAGTGGTCCATCAATC* biotin
Sequence primer ATACACCATGGACACAGT
Forward PA H5N1/H1N1 GTGCGACAATGCTTCAATCCA
Reverse PA H5N1/H1N1 GTGTGCATATTGCAGCAAA * biotin
Sequence primer CAATGCTTCAATCCAA
Forward NP H5N1/H1N1 GAGCTCTCGGACGAAAAGG
Reverse NP H5N1/H1N1 CTCTGCATTGTCTCCGAAGAA * biotin
Sequence primer TGCCTTCCTTTGACAT
Forward NA H5N1/H1N1 GGCATAATAACAGACACTATCAAG
Reverse NA H5N1/H1N1 CCATTACTTGGTCCATC * biotin
Sequence primer GACACTATCAAGAGTTGGAG
Forward MA H5N1/H1N1 GAGTCTTCTAACCGAGGTCGAAAC * biotin
Reverse MA H5N1/H1N1 GTGTTCTTTCCTGCAAAGAC
Sequence primer GCCTGACGGGATGATA
Forward NS H5N1/H1N1 AGGGTGACAAAAACATAATGGA
Reverse NS H5N1/H1N1 CAAGGAATGGGGCATCACCC * biotin
Sequence primer GTGACAAAAACATAATGGA
doi:10.1371/journal.pone.0059889.t001
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Results
In vitro Selection of H5 Reassortant Viruses
Reverse genetics was used to generate mixtures of reassortant
viruses in 293T cells, by co-transfecting eight plasmids that encode
the H5N1 virus genome together with seven plasmids encoding
the pH1N1, H3N2 or sH1N1 virus genome, omitting their HA
gene. The 293T cell supernatants were passaged, in quadruplicate,
under limiting dilution conditions to allow selective outgrowth of
viruses with high in vitro replication rates. After three passages, the
genome composition of these viruses was determined by sequenc-
ing (Table 2). The predominant virus population was identified for
almost all passaged virus mixtures by sanger sequencing, with
minor virus variants representing less than 20% of the virus
mixture (estimated detection limit for sanger sequencing). Point
mutations were not observed in the proportion of the genome
analyzed. Upon H5N1-pH1N1 transfection and passaging of the
virus mixtures, wild type (wt) H5N1 was recovered in one attempt
and H5N1-pH1N1-reassortants in three attempts (Table 2). These
reassortants incorporated the pH1N1 matrix (M) gene (H5-pH1M),
or the pH1N1 M, neuraminidase (NA) and non-structural (NS)
genes (H5-pH1NA,M,NS), or the pH1N1 M, NA, NS and
polymerase complex genes PB2, PB1 and PA (H5-
pH1NA,M,NS,PB2,PB1,PA).
Upon H5N1-H3N2 transfection and passaging, wtH5N1 was
recovered in one attempt, whereas three reassortant viruses were
recovered that had the NA gene of H3N2 (H5-H3NA). In one of
the reassortant viruses that contained the NA gene of H3N2, a
mixed population was present for the M gene (approximately 50%
H5N1 and 50% H3N2; H5-H3NA,M) (Table 2).
Four different genome compositions were identified upon
H5N1-sH1N1 transfection and passaging: wtH5N1 was recovered
as well as three reassortant viruses containing the sH1N1 M or NA
or M and NA genes (H5-H1NA, H5-H1M and H5-H1NA,M)
(Table 2).
In vitro Characterization of H5 Reassortant Viruses in
MDCK Cells
The data obtained from the in vitro selection experiments
suggest that the NA and M genes of all three tested human
influenza viruses as well as the NS gene of pH1N1 frequently
substituted their H5N1 counterparts. Therefore, reverse genetics
was used to generate H5 reassortants that contained one (NA, M
or NS), two (NA and M), or three (NA, M and NS) genes of
pH1N1, H3N2 or sH1N1 (Table 3) and their replication kinetics
was subsequently evaluated in MDCK cells. MDCK cells were
inoculated with reassortant viruses at an MOI of 0.01, after which
the supernatants were harvested at fixed time points and virus
titers were determined in MDCK cells. In general, H5 reassortant
viruses containing gene segments of pH1N1 showed similar virus
titers compared to wtH5N1 (Fig. 1A), although H5-pH1M and H5-
pH1NA,M,NS reassortant viruses were produced at a slightly higher
level at 24 and 48 hours post-inoculation (pi), whereas H5-pH1NA
had a lower replication rate compared to wtH5N1. The virus
replication of most H5N1-H3N2 reassortant viruses was similar to
that of wtH5N1 in MDCK cells (Fig. 1B), however H5-H3M and
H5-H3NS reassortant viruses had slightly increased virus titers at
24 and 48 hours pi, whereas H5-H3NA had a lower virus titer at 48
hours pi. Almost all H5 reassortant viruses with sH1N1 gene
segments replicated to similar virus titers compared to wtH5N1,
although H5-sH1NA had a lower virus titer at 48 hours pi,
compared to wtH5N1. Although the differences in replication
kinetics between the wtH5N1 and the H5 reassortant viruses were
rather small, it seemed that incorporation of any of the three NA’s
attenuated virus replication at 48 hours pi.
In vitro Characterization of H5 Reassortant Viruses in
wdHBE Cells
Influenza viruses infect cells of the respiratory tract of humans.
Therefore, we evaluated the replication kinetics of the reassortant
viruses in wdNHBE cells.
To characterize the wdNHBE cells, immunohistochemistry was
used to identify ciliated cells, mucus-producing goblet cells and
tight junctions. Cultures were also double stained for ciliated cells
and tight junctions. For further characterization, the sialic acid
(SA) receptor distribution on wdNHBE cells was determined by
lectin histochemistry using MAL-II which recognizes the a2.3-
linked SA and SNA which recognizes a2.6-linked SA, the
receptors for avian and human influenza viruses respectively.
Table 2. Predominant virus genome composition upon in vitro selection of mixtures of H5N1-pH1N1, H5N1-H3N2 and H5N1-
sH1N1 reassortants.
Replicates PB2 PB1 PA HA NP NA M NS
H5-pH1 1 H5 H5 H5 H5 H5 H5 pH1 H5
H5-pH1 2 pH1 pH1 pH1 H5 H5 pH1 pH1 pH1
H5-pH1 3 H5 H5 H5 H5 H5 H5 H5 H5
H5-pH1 4 H5 H5 H5 H5 H5 pH1 pH1 H5/pH1*
H5-H3 1 H5 H5 H5 H5 H5 H3 H5 H5
H5-H3 2 H5 H5 H5 H5 H5 H5 H5 H5
H5-H3 3 H5 H5 H5 H5 H5 H3 H5/H3** H5
H5-H3 4 H5 H5 H5 H5 H5 H3 H5 H5
H5-sH1 1 H5 H5 H5 H5 H5 H5 sH1 H5
H5-sH1 2 H5 H5 H5 H5 H5 sH1 sH1 H5
H5-sH1 3 H5 H5 H5 H5 H5 sH1 H5 H5
H5-sH1 4 H5 H5 H5 H5 H5 H5 H5 H5
*A 25/75 population of NS H5 and pH1 was detectable.
**A 50/50 population of M H5 and H3 was detectable.
doi:10.1371/journal.pone.0059889.t002
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This data is in agreement with the general pattern of SA receptor
distribution on wdNHBE cells cultured in vitro: a2.3-linked SA
receptors are expressed predominantly on ciliated cells and to a
lesser extent on nonciliated cells and a2.6-linked SA receptors are
expressed mainly on nonciliated cells and to a lesser extent on
ciliated cells [16].
To study the replication kinetics of the H5 reassortant viruses,
wdNHBE cells were inoculated with an MOI of 0.02. Growth
medium was added for ten minutes to harvest virus at fixed
time points. None of the H5N1-pH1N1 (Fig. 2A), H5N1-H3N2
(Fig. 2B) and H5N1-sH1N1 (Fig. 2C) reassortant viruses
replicated to higher virus titers then wtH5N1 in wdNHBE
cells. Some H5 reassortant viruses (H5-pH1NS, H5-H3NA,M,NS
and H5-sH1NA,M) even displayed virus titers at 48 hours p.i.
that were .1.5 log10 TCID50/ml lower compared to the
wtH5N1 virus titer.
H5N1-pH1N1 Reassortant Viruses in Ferrets
The ferret model was used to select for H5N1-pH1N1
reassortant viruses with highest replication in vivo, and to
evaluate the ability of this virus to be transmitted via aerosols
or respiratory droplets. Two ferrets were inoculated intranasally
with 107.3 TCID50 of the MDCKP1 H5N1-pH1N1 reassortant
virus mixture. A recipient ferret was placed in a transmission
cage adjacent to each donor ferret one day later. Throat and
nose swabs were collected at 1, 3, 5 and 7 dpi and dpe. Virus
shedding peaked in the inoculated animals at 1 dpi, with virus
titers up to 104 TCID50/ml in throat swabs (Fig. 3), and this
shedding continued until 7 dpi. Overall, the amount and
duration of virus shedding of ferrets inoculated with the
reassortant H5N1-pH1N1 mixture was lower compared to
those of wild type H5N1-inoculated ferrets in our previous
experiment [22]. None of the viruses in the H5N1-pH1N1
reassortant mixture was transmitted to the recipient ferrets via
Figure 1. Replication kinetics of H5N1-pH1N1, H5N1-H3N2 and H5N1-sH1N1 reassortant viruses in MDCK cells. MDCK cells were
inoculated with 0.01 TCID50/cell of H5N1 (black), H5 reassortant viruses harboring the NA (grey), M (red), NS (purple), NA and M (blue) and NA, M and
NS (green) of pH1N1 (A), H3N2 (B) or sH1N1 (C) and supernatant samples were harvested 6, 12, 24, and 48 h later. Geometric mean titers were
calculated from two independent experiments, error bars indicate standard deviations. The lower limit of detection is indicated by the dotted line.
doi:10.1371/journal.pone.0059889.g001
Table 3. H5 Reassortant influenza viruses rescued via reverse genetics.
Reassortant virus PB2 PB1 PA HA NP NA M NS
H5N1 H5 H5 H5 H5 H5 H5 H5 H5
H5-pH1NA H5 H5 H5 H5 H5 pH1 H5 H5
H5-pH1M H5 H5 H5 H5 H5 H5 pH1 H5
H5-pH1NS H5 H5 H5 H5 H5 H5 H5 pH1
H5-pH1NA,M H5 H5 H5 H5 H5 pH1 pH1 H5
H5-pH1NA,M,NS H5 H5 H5 H5 H5 pH1 pH1 pH1
H5-H3NA H5 H5 H5 H5 H5 H3 H5 H5
H5-H3M H5 H5 H5 H5 H5 H5 H3 H5
H5-H3NS H5 H5 H5 H5 H5 H5 H5 H3
H5-H3NA,M H5 H5 H5 H5 H5 H3 H3 H5
H5-H3NA,M,NS H5 H5 H5 H5 H5 H3 H3 H3
H5-sH1NA H5 H5 H5 H5 H5 sH1 H5 H5
H5-sH1M H5 H5 H5 H5 H5 H5 sH1 H5
H5-sH1NS H5 H5 H5 H5 H5 H5 H5 sH1
H5-sH1NA,M H5 H5 H5 H5 H5 sH1 sH1 H5
H5-sH1NA,M,NS H5 H5 H5 H5 H5 sH1 sH1 sH1
doi:10.1371/journal.pone.0059889.t003
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the aerosol or respiratory droplet route, since no virus could be
detected in the throat and nose swabs collected from the
recipient ferrets (Fig. 3).
The genetic composition of the H5N1-pH1N1 reassortant
viruses in throat swabs collected from the donor ferrets as well as
in the MDCKP1 virus stock that was used as inoculum, was
analyzed using pyrosequencing. In the MDCKP1 virus stock, the
vast majority of the PB2, PB1, PA, NP and NS genes was derived
from H5N1, and these H5 genes remained dominant in both
ferrets until 7 dpi: 9565%, 10060%, 9862%, 9064% and
9663% respectively (Fig. 4). In contrast, the NA and M gene
segments of pH1N1 virus origin were dominant in the inoculum.
In addition, these pH1N1 genes were still present in the
reassortant mixture collected from ferrets at 7 dpi, although the
proportion of these genes had decreased during the course of
infection to 4664% and 2864% for NA and M respectively
(Fig. 4).
Discussion
Genetic reassortment is an important mechanism in the
evolution of influenza viruses yielding strains with novel genetic
and phenotypic traits. At least two human influenza pandemics in
the last century were linked to lineages where circulating human
influenza viruses reassorted with influenza genes of non-human
(probably avian) origin [9]. To study the potential of reassortment
between the HPAI H5N1 virus and contemporary human
influenza viruses (pH1N1, H3N2 and sH1N1), we used an in vitro
selection method to identify the reassortant viruses that are most
likely to emerge. The HA of the contemporary human influenza
viruses was omitted in these experiments to make sure that only
viruses containing an H5 HA were generated. In this way, a
mixture of up to 128 (27) possible different reassortant viruses was
generated that was subsequently passaged in MDCK cells under
limiting dilution conditions to allow selective outgrowth of viruses
with high in vitro replication rates. It should be noted that virus
replication in MDCK cells may not reflect natural selection of
reassortant viruses in humans. However, we have previously
shown that with this method, reassortant viruses with enhanced
pathogenicity in ferrets could be identified, thereby emphasizing
the usefulness of this method [18].
Analysis of the genetic composition of the viruses that were
obtained using the in vitro selection method in the present study,
showed that wtH5N1 virus was recovered in 1 out of 4 attempts in
all three H5N1-human influenza genome mixing experiments. In
all other attempts, the NA and M genes of pH1N1, H3N2 and
sH1N1 as well as the NS gene of pH1N1 were selected by HPAI
H5 virus, after replication in mammalian cells (Table 2).
In addition, the ability of H5N1 and pH1N1 influenza viruses to
reassort has recently been investigated by others. In this study,
MDCK cells were coinfected with these two viruses, resulting in
the selection of similar reassortant viruses, harboring the NA, M,
and NS gene segments of pH1N1 [13]. In another study, ferrets
were co-infected with avian H5N1 and human H3N2 resulting in
reassortant viruses that had also incorporated the NA, M and NS
gene segments of a human H3N2 virus [11]. Thus, our
transfection based approach yielded similar data as with other
methods.
When we studied the replication kinetics of the H5 reassortant
viruses that were detected after in vitro selection in MDCK cells,
we found that only a few H5 reassortant viruses had a slightly
Figure 2. Replication kinetics of H5N1-pH1N1, H5N1-H3N2 and H5N1-sH1N1 reassortant viruses in wdNHBE cells. wdNHBE cells were
inoculated with 0.02 TCID50/cell of H5N1 (black), H5N1 reassortant viruses consisting of the NA (grey), M (red), NS (purple), NA and M (blue) and NA,
M and NS (green) of pH1N1 (A), H3N2 (B) or sH1N1 (C) and samples were harvested 1, 6, 12, 24, and 48 h later. Geometric mean titers were calculated
from two independent experiments, error bars indicate standard deviations. The lower limit of detection is indicated by the dotted line.
doi:10.1371/journal.pone.0059889.g002
Figure 3. Replication and transmission of H5N1-pH1N1 reas-
sortant virus in ferrets. Two ferrets were inoculated intranasally with
107.3 TCID50 of the MDCKP1 H5N1-pH1N1 reassortant virus mixture and
subsequently housed individually in transmission cages (A, B). A naı¨ve
recipient ferret was added to a cage adjacent to each transmission cage
at 1dpi (A, B). Virus titers in throat (black) and nose swabs (white) of the
donor ferrets (lines) and recipient ferrets (bars) were determined by
endpoint titration in MDCK cells. The lower limit of detection is
indicated by the dotted line.
doi:10.1371/journal.pone.0059889.g003
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increased replication capacity compared to the wt H5N1 virus
(Fig. 1). This effect could for the most part be attributed to the M
gene segment of pH1N1 and H3N2. In contrast, when the NA of
H5N1 was exchanged by the NA of one of the three human
influenza viruses, the replication kinetics were slower compared to
the wtH5N1 virus, which is in agreement with previous findings
when H5N1-H3N2 reassortment was studied [11].
In wdNHBE cells, HPAI H5N1 replicates to lower titers
compared to pH1N1, H3N2 and sH1N1 (data not shown and
[24]). However, when the replication capacity of H5 reassortant
viruses was investigated, no increased replication was demonstrat-
ed for any of the H5 reassortants, when compared to wtH5N1. It is
possible that this poor replication of H5N1 virus compared to the
human influenza viruses is the result of the avian receptor
specificity of H5N1. Modification of the receptor binding
preference of H5N1 to the human type receptors may result in
increased replication in wdNHBE cells, and may to some extent
compensate for the need of reassortment with human influenza
viruses.
The data obtained with the in vitro selection experiments showed
that especially the M and NA gene segments from human
influenza viruses are preferentially selected by avian H5N1.
However when these reassortant viruses were investigated in vitro
none of the reassortant H5 viruses had an apparent increase in
replication capacity compared to wtH5N1. This observation may
explain why wtH5N1 was also recovered in all three in vitro
selection experiments.
To study if reassortment between H5N1 and pH1N1 can be
beneficial for virus replication in mammals, ferrets were inoculated
with a mixture of reassortant viruses (MDCKP1 virus stock) and
the virus composition was determined at different time points
during the course of infection using pyrosequencing. In the
inoculum, the H5 polymerase complex genes PB2, PB1 and PA, as
well as the H5N1 NP and NS genes were predominant, with only
a small percentage of these genes being derived from pH1N1.
Although the H5N1 polymerase genes did not contain the well-
known mutations in PB2 (E627K or D701N) that have been
shown to be required for optimal replication of avian influenza
viruses in mammals [25,26], the proportion of the pH1N1
polymerase complex genes in the virus mixture remained low
during the course of infection. In contrast, the proportion of the
pH1N1 NA and M genes in the MDCKP1 virus mixture were
higher than those of the H5N1 counterparts, but this proportion
decreased slowly over time. It should be noted that the assessment
of the preference of reassortant H5 viruses for H5N1 or pH1N1
gene segments would be more reliable if all gene segments would
be present in equal copy numbers in the inoculum. Unfortunately,
the generation of reassortants by transfecting 293T cells with
Figure 4. Virus composition in ferrets inoculated with H5N1-pH1N1 reassortant virus during the course of infection. Two ferrets were
inoculated intranasally with 107.3 TCID50 of the MDCKP1 H5N1-pH1N1 reassortant virus mixture. At day 1, 3, 5 and 7 dpi throat swabs were collected
from both ferrets (F1 and F2). In these throat samples, as well as the MDCKP1 inoculum, the ratio of the H5N1 (red) and pH1N1 (blue) gene segments
(PB2, PB1, PA, NP, NA, M and NS) was determined by pyrosequencing. ND: no detection of viral gene segments by PCR.
doi:10.1371/journal.pone.0059889.g004
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plasmids harboring the different gene segments apparently
resulted in a biased virus population with already a strong
preferred use of some of the H5 genes. However, gene segments
that represented only a small proportion of the population (like the
pH1N1 polymerase genes) should have increased in number if
there would have been an apparent selective advantage for the
viruses.
In the same ferret experiment, we investigated whether an
airborne-transmissible H5N1 virus was present in the reassortant
virus mixture. However, no aerosol or respiratory droplet
transmission was detected, since no virus could be detected in
respiratory samples collected from the naı¨ve recipient ferrets. This
may be the result of the low amount of virus that was shed by the
donor ferrets, combined with the receptor binding preference of
the H5N1 HA for a2,3-linked SA that are absent in the upper
respiratory tract of ferrets. This switch in receptor preference was
recently shown to be crucial for airborne transmission of H5N1
viruses [3,6]. However, H5N1 viruses that were only mutated to
acquire a preference for human a2,6-linked SA receptors were not
transmitted between ferrets, suggesting that additional genetic
changes are needed [6,27]. Recently Imai et al. showed that in
addition to receptor binding preference for a2,6-linked SAs, two
additional mutations in HA are required to confer a H5N1-
pH1N1 reassortant, carrying the H5 HA and the other genes from
pH1N1, airborne-transmissible between ferrets [3]. Moreover,
recently we discovered that a fully avian H5N1 virus, with a
preference for for human a2,6-linked SA receptors, can acquire
the ability to be transmitted between ferrets without the need for
reassortment [6].
Although none of the reassortant viruses identified and
evaluated in our study have an evident replication advantage
over their parental viruses, the generated reassortant viruses were
also not found to be severely attenuated. Given that only a few
mutations are necessary to confer airborne transmission of a
H5N1-pH1N1 reassortant between ferrets, the emergence of
reassortant viruses between human and avian influenza viruses but
also between human and porcine influenza viruses should be
monitored carefully.
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